<DOC>
	<DOCNO>NCT02322918</DOCNO>
	<brief_summary>The purpose study determine candidate polymorphism brain-derived neurotrophic factor ( BDNF ) catechol-o-methyl transferase ( COMT ) predictive psychosis disorder severity , symptomology , resolution patient BCPP . A secondary objective form biorepository blood saliva sample patient BCPP genetic , proteonomic pharmacogenomic study may do gain insight genetic basis difference psychosis disorder presentation manifestation , difference response antipsychotic drug treatment .</brief_summary>
	<brief_title>The BC Psychosis Program Biobank Database Genetic Polymorphisms Their Associations With Psychosis Disorder</brief_title>
	<detailed_description>This population-based , genetic-association , candidate polymorphism study . It involve prospective retrospective component . A blood draw saliva sample perform participant 's admission BCPP , may occur point participant 's length stay . When participant deem 'Ready Discharge ' his/her attend psychiatrist BCPP , full phenotype obtain via retrospective chart review . Genetic analysis determination protein level perform chart review . Following fulfillment primary study objective , remain blood saliva sample store biobank long-term .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<criteria>Admission BCPP . Has provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>